Neurohypophysial AVP concentration in stroke patients

Area of Science:

• Neuroendocrinology
• Cerebrovascular Diseases
• Neuropeptides

Background:

• Arginine vasopressin (AVP) is a key neurohypophysial hormone involved in regulating water balance and blood pressure.
• Altered AVP levels have been implicated in various neurological conditions, but its specific role in different stroke types remains unclear.
• Understanding AVP dynamics in stroke may offer insights into pathophysiology and potential therapeutic targets.

Purpose of the Study:

• To investigate and compare neurohypophysial arginine vasopressin (AVP) concentrations in patients with different types of stroke (cerebral infarction, intracerebral hemorrhage, subarachnoid hemorrhage) and healthy controls.
• To explore the potential relationship between ischemic brain damage and elevated AVP levels.

Main Methods:

• Radioimmunoassay (RIA) was employed to quantify neurohypophysial AVP concentrations.
• Patient cohorts included individuals with cerebral infarction (n=9), intracerebral hemorrhage (n=11), subarachnoid hemorrhage (n=5), and a control group (n=5).

Main Results:

• Neurohypophysial AVP concentration was significantly elevated by 225.8% in patients with cerebral infarction compared to controls (P < 0.05).
• No significant changes in AVP concentrations were observed in patients with intracerebral or subarachnoid hemorrhage.
• Clinical manifestations of stress, such as brain herniation, gastrointestinal bleeding, and hyperglycemia, were more frequent in hemorrhagic stroke patients.

Conclusions:

• Ischemic brain damage in cerebral infarction may contribute to the observed elevation in neurohypophysial AVP concentration.
• AVP levels do not appear to be significantly altered in the acute phase of intracerebral or subarachnoid hemorrhage.
• Further research is warranted to elucidate the precise mechanisms linking ischemic stroke and AVP dysregulation.